Ftse Mib
34.375,92
-0,59%
DAX
18.590,89
-0,95%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
64.683,19
-0,26%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sun BioPharma Inc (SNBP) Sun BioPharma Inc (SNBP) Notizie

SNBP

Sun BioPharma (SNBP)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SNBP
DataOraFonteTitoloSimboloCompagnia
01/02/201014:30PR Newswire (US)China's Basic Medical Insurance to Cover Sinobiopharma's Flagship ProductNASDAQ:SNBP
25/01/201014:30PR Newswire (US)Chinese State Food and Drug Administration Approves Company Facility for Producing Solid Dosage PerindoprilNASDAQ:SNBP
19/01/201014:30PR Newswire (US)Sinobiopharma Announces Second Quarter 2010 Financial ResultsNASDAQ:SNBP
19/11/200913:00PR Newswire (US)Zacks Equity Research Initiates Coverage on SinobiopharmaNASDAQ:SNBP
16/11/200913:00PR Newswire (US)Sinobiopharma has Production Rights to 23 Drugs Listed in China's National Essential Drugs ListNASDAQ:SNBP
21/10/200907:00PR Newswire (US)Sinobiopharma Presents Highlights from Unaudited First Quarter Financial Results for the 3 Month Period Ended August 31, 2009NASDAQ:SNBP
08/10/200907:00PR Newswire (US)Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw MaterialNASDAQ:SNBP
30/09/200905:00PR Newswire (US)Sinobiopharma, Inc. Appoints New Chief Financial Officer and Director to the BoardNASDAQ:SNBP
21/09/200919:26PR Newswire (US)Emissary Capital Group Initiates Coverage on SinobiopharmaNASDAQ:SNBP
18/06/200915:30PR Newswire (US)Sinobiopharma Receives Trademark Approval and Authentication From Chinese Government For Its 'Tai' Drug SeriesNASDAQ:SNBP
21/05/200915:30PR Newswire (US)Sinobiopharma Applies For Two Chinese Patents For Cisatracurium BesylateNASDAQ:SNBP
20/05/200915:15PR Newswire (US)Sinobiopharma Updates on Progress; Projects Increases in Sales and Revenues In 2009NASDAQ:SNBP
14/05/200915:15PR Newswire (US)Sinobiopharma Announces 350% Increase in Production of Its Flagship Drug in the First Quarter of 2009 Over the Same Period in 20NASDAQ:SNBP
11/05/200921:49PR Newswire (US)Sinobiopharma Announces SFDA Approval of Anti-Hypertension Drug PerindoprilNASDAQ:SNBP
27/04/200922:37PR Newswire (US)Sinobiopharma Secures Rights to Seven Key PatentsNASDAQ:SNBP
24/04/200922:06PR Newswire (US)Sinobiopharma Reports a 141% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 200NASDAQ:SNBP
24/04/200921:30PR Newswire (US)Sinobiopharma Reports a 41% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009NASDAQ:SNBP
13/04/200922:00PR Newswire (US)Sinobiopharma, Inc. Signs Sales Contract for Flagship ProjectNASDAQ:SNBP
08/04/200922:26PR Newswire (US)Sinobiopharma, Inc. Appoints New Director of MarketingNASDAQ:SNBP
06/04/200922:00PR Newswire (US)Sinobiopharma Applies for Chinese Patent to Develop the Next Generation of Anti-Hypertension CompoundsNASDAQ:SNBP
03/04/200922:00PR Newswire (US)Sinobiopharma Signs Export Agreement With U.S. Pharmaceutical SupplierNASDAQ:SNBP
24/03/200915:00PR Newswire (US)Phase IV Multi-center Clinical Study of Kutai Concludes in NanjingNASDAQ:SNBP
29/01/200917:03PR Newswire (US)Sinobiopharma Reports Financial Highlights for Six-Month Period Ending November 30, 2008NASDAQ:SNBP
10/12/200821:05PR Newswire (US)Sinobiopharma Reports Highlights of Third Quarter Results for Its Operating Subsidiary, Dong Ying ChinaNASDAQ:SNBP
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SNBP

La tua Cronologia

BIT
UC80K9
Unicredit Bank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network